Akhil Santhosh
Jan 25, 2025, 03:14
Akhil Santhosh: Carboplatin, Paclitaxel, and Atezolizumab in the Treatment of Thymic Cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“MARBLE study: single arm phase 2 study of carbo+ pacli+ atezo in thymic cancer (n=48)
ORR 56.3%, DCR 97.2%
1 year PFS 43.3%, 1 Year OS 91.3%
all patients had any grade IRAE, 66.7% grade 3.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 25, 2025, 03:11
Jan 25, 2025, 03:02
Jan 25, 2025, 02:59
Jan 25, 2025, 02:57
Jan 25, 2025, 02:53
Jan 25, 2025, 02:51
Jan 25, 2025, 02:50
Jan 25, 2025, 02:46